Interactive Health Communication for longer, better lives.

'Angry' Cell Treatment Harnesses Power Of Immune System To Destroy Cancer Cells

The company's new treatment, which can be used for virtually any type of cancer, works in two ways, firstly - like BMT - it disables the ability of the tumor to fight the immune response, and secondly it trains the patient's immune system to kill the cancer cells wherever it finds them.

I this article means a mini-allo transplant not a peripheral blood stem cell transplant-

http://www.medicalnewstod...

Heres'a a post from the ACOR list that I found really interesting. I am particularly in interested in the role of the immune system in battling MM, because the focus of the Gerson protocol is detoxification and then rebuilding the immune system. Most conventional treatments, as we know, decimate the immune system, and medical wisdom warns us against boosting the immune system. But what if a strong immune system can hold MM in abeyance indefinitely? We don't need to "cure" it if it is "incurable," as long as we can hold it in check. Some accounts I've read of the Gerson protocol indicate that the protocol allowed patient's bodies to contain their cancers and wall them off from the rest of the body, rather than killing the tumor outright.

"from Newswise and Washington University Saint Louis School of Medicine Rita Kautz, Attica, NY, USA

Immune System Can Drive Cancers Into Dormant  State part I.

Newswise — A multinational team of researchers has shown for the first time
that the immune system can stop the growth of a cancerous tumor without
actually killing it. Scientists have been working for years to use the immune system to eradicate cancers, a technique known as immunotherapy. The new findings prove an alternate to this approach exists: When the cancer can't be killed with immune attacks, it may be possible to find ways to use the immune system to contain it. The results also may help explain why some tumors seem to suddenly stop growing and go into a lasting period of dormancy. The study appears today in the advance online publication of Nature. "Thanks to the animal model we have developed, scientists can now reproduce this condition of tumor dormancy in the laboratory and look directly at cancer cells being held in check by the immune system," says co-author Robert Schreiber, Ph.D., Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis. "That will allow us to see if we can model this state therapeutically.""

 

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
Please type in these five (5) letters or numbers to verify you aren't a SPAM Bot!
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.